bluebird bio confirms Ayrmid has not delivered binding offer, shares dive 9%
bluebird bio confirms Ayrmid has not delivered binding offer, shares dive 9%
Key deals this week: xAI acquires X; bluebird bio, Nvidia, Dollar Tree and more
bluebird bio sees higher offer for company from Ayrmid Pharma
bluebird bio stock slides for second day on buyout news
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker - CNBC
bluebird bio announces take-private deal with Carlyle and SK Capital
38.87MUSD
taip
Common Stock
Pertukaran
NASDAQ
Kod matawang
USD
Nama Mata Wang
US Dollar
Nama negara
USA
ISO negara
US
ADALAH DALAM
US09609G2093
CUSIP
09609G100
Sektor
Healthcare
industri
Biotechnology
Akhir Tahun Fiskal
December
tarikh IPO
-
Dikemaskini Pada
-
Nisbah PE
-
Nisbah PEG
0.32
Nilai buku
-3.24
Bahagian Dividen
-
Hasil Dividen
-
Bahagian Pendapatan
-24.84
Harga Sasaran Wall Street
6.50
Anggaran EPS Tahun Semasa
0.30
Anggaran EPS Tahun Depan
-11.50
EPS Anggaran Suku Tahun Semasa
-6.295
Anggaran EPS Suku Tahun Seterusnya
-3.8967
Suku Terkini
-
Hasil TTM
83,807,000
Keuntungan Kasar TTM
-5,573,000
EBITDA
-206,455,008
Margin keuntungan
-287.23%
Pulangan Atas Aset TTM
-31.00%
Pulangan Atas Ekuiti TTM
-295.35%
Hasil Sesaham TTM
8.65
Pertumbuhan Hasil Qtly YOY
391.70%
Eps TTM yang dicairkan
-24.84
Pertumbuhan Pendapatan Qtly YOY
0.00%
PE mengekori
0.00
PE ke hadapan
0
Harga Jualan TTM
0.4638
Buku Harga MRQ
0.726
Hasil Nilai Perusahaan
3
EBITDA Nilai Perusahaan
-1
151.70
1.87%95.64
0.73%433.03
0.64%237.66
0.62%574.45
0.60%551.09
0.48%697.42
0.00%85.48
-3.70%76.77
-1.60%258.35
-0.25%